News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
20,406 Results
Type
Article (1124)
Company Profile (1)
Press Release (19279)
Multimedia
Podcasts (4)
Webinars (1)
Section
Business (7321)
Career Advice (80)
Deals (1086)
Drug Delivery (5)
Drug Development (2205)
Employer Resources (3)
FDA (412)
Job Trends (488)
News (10136)
Policy (699)
Tag
2027 BioCapital Standard (1)
Academia (67)
Accelerated approval (3)
ADA (1)
Adcomms (1)
Allergies (7)
Alliances (1640)
ALS (7)
Alzheimer's disease (82)
Antibody-drug conjugate (ADC) (17)
Approvals (428)
Artificial intelligence (36)
ASCO (8)
Autoimmune disease (24)
Bankruptcy (7)
Best Places to Work (421)
Biologics (9)
Biosimilars (8)
BioSpace Insights (8)
Biotechnology (1)
Bispecific (2)
Bladder cancer (3)
Brain cancer (4)
Breast cancer (12)
Cancer (202)
Cardiovascular disease (15)
Career advice (71)
CAR-T (10)
CDC (1)
CDMO (9)
Cell therapy (33)
Cervical cancer (1)
Clinical research (1992)
Collaboration (100)
Commercialization (3)
Compensation (19)
Complete response letters (1)
COVID-19 (78)
CRISPR (4)
C-suite (90)
Cystic fibrosis (2)
Data (310)
Decentralized trials (1)
Denatured (3)
Depression (7)
Dermatology (3)
Diabetes (24)
Diagnostics (338)
Digital health (1)
Diversity (3)
Diversity, equity & inclusion (2)
Drug discovery (23)
Drug pricing (11)
Duchenne muscular dystrophy (5)
Earnings (2351)
Editorial (2)
Employer resources (4)
ESMO (15)
Events (3757)
Executive appointments (74)
FDA (562)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (8)
Funding (62)
Gene editing (8)
Generative AI (5)
Gene therapy (12)
GLP-1 (18)
Government (89)
Guidances (22)
Healthcare (711)
Hematology (8)
HIV (1)
Huntington's disease (1)
IgA nephropathy (5)
Immunology and inflammation (12)
Immuno-oncology (2)
Indications (7)
Infectious disease (98)
Inflammatory bowel disease (9)
Inflation Reduction Act (1)
Influenza (18)
Intellectual property (10)
Interviews (30)
IPO (468)
IRA (3)
Job creations (99)
Job search strategy (34)
JPM (5)
Kidney disease (3)
Layoffs (12)
Leadership (1)
Legal (160)
Licensing (4)
Liver cancer (1)
Longevity (3)
Lung cancer (30)
Lung diease (1)
Lymphoma (13)
Machine learning (6)
Management (2)
Manufacturing (63)
MASH (4)
Medical affairs (1)
Medical device (494)
Medtech (515)
Melanoma (7)
Mergers & acquisitions (669)
Metabolic disorders (53)
mRNA (30)
Multiple sclerosis (4)
Neurodegenerative disease (29)
Neuropsychiatric disorders (7)
Neuroscience (152)
NextGen: Class of 2026 (213)
Non-profit (142)
Obesity (20)
Opinion (6)
Ovarian cancer (2)
Pain (10)
Pancreatic cancer (15)
Parkinson's disease (16)
Patents (12)
Patient recruitment (42)
Patient selection (2)
Peanut (4)
People (2621)
Peptides (1)
Pharmacy benefit managers (1)
Phase 1 (712)
Phase 2 (935)
Phase 3 (550)
Pipeline (453)
Policy (10)
Postmarket research (39)
Preclinical (239)
Prostate cancer (8)
Psychedelics (1)
Radiopharmaceuticals (24)
Rare diseases (35)
Real estate (161)
Recruiting (1)
Regenerative medicine (1)
Regulatory (645)
Reports (1)
Research institute (65)
Resumes & cover letters (15)
RSV (1)
Schizophrenia (19)
Series A (7)
Series B (10)
Sickle cell disease (4)
Special edition (1)
Spinal muscular atrophy (2)
Startups (146)
Supply chain (4)
Tariffs (6)
The Weekly (1)
Vaccines (49)
Venture capital (2)
Weight loss (10)
Women's health (2)
Date
Last 7 days (23)
Last 30 days (107)
Last 365 days (925)
2026 (853)
2025 (922)
2024 (1271)
2023 (1515)
2022 (1735)
2021 (1822)
2020 (1749)
2019 (1693)
2018 (1181)
2017 (1123)
2016 (941)
2015 (1127)
2014 (692)
2013 (498)
2012 (567)
2011 (533)
2010 (406)
Location
Africa (25)
Alabama (3)
Arizona (4)
Asia (938)
Australia (383)
California (630)
Canada (149)
China (35)
Colorado (55)
Connecticut (22)
Delaware (8)
Europe (3880)
Florida (38)
Georgia (18)
Idaho (4)
Illinois (18)
Indiana (14)
Iowa (1)
Japan (34)
Kansas (2)
Kentucky (2)
Louisiana (1)
Maine (2)
Maryland (82)
Massachusetts (400)
Michigan (4)
Minnesota (19)
Missouri (8)
Montana (3)
Nevada (11)
New Hampshire (10)
New Jersey (114)
New York (62)
North Carolina (84)
North Dakota (1)
Northern California (382)
Ohio (12)
Oregon (1)
Pennsylvania (131)
South America (32)
South Dakota (1)
Southern California (169)
Tennessee (1)
Texas (25)
United States (1727)
Utah (18)
Virginia (6)
Washington D.C. (3)
Washington State (18)
Wisconsin (4)
20,406 Results for "chr hansen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Novozymes and Chr. Hansen announce name of future combined company; Novonesis
Novozymes and Chr. Hansen announced their future name ‘Novonesis’. The name reflects the beginning of an era of biosolutions where Novonesis will unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.
December 13, 2023
·
13 min read
Deals
The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
On December 12, 2022, Novozymes and Chr. Hansen entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies.
January 29, 2024
·
8 min read
IN PARTNERSHIP WITH AGC BIOLOGICS
Your Scale, Your Terms: How Modular Bioreactors Are Redefining Capacity & Manufacturing Strategies
Principal Scientist Anders Cai Holm Hansen explains how CDMO AGC Biologics uses its global, single-use network and a strategy emphasizing “scale-out” manufacturing, to derisk demand uncertainty, speed timelines and conserve cash for emerging drug developers.
April 13, 2026
·
7 min read
·
Jennifer C. Smith-Parker
Deals
Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market
Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/ Denmark , to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an agreement to acquire all shares in Jennewein Biotechnologie, the innovation a
September 22, 2020
·
4 min read
Deals
UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries.
July 28, 2020
·
3 min read
Business
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care.
February 6, 2024
·
8 min read
Press Releases
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary
May 21, 2025
·
4 min read
Business
LIfT BioSciences appoints Dr Bo Rode Hansen and Dr Marco Gottardis to its Board of Directors
LIfT BioSciences, a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy, announces the appointments of Dr Bo Rode Hansen PhD, MBA and Dr Marco Gottardis, PhD as Non-Executive Directors of its Board.
December 21, 2023
·
4 min read
Press Releases
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary effective immediately
May 21, 2025
·
4 min read
Business
Prota Therapeutics Partners With World Leading Bioscience Company, Chr. Hansen
Prota Therapeutics partners with leading global bioscience company, Chr. Hansen, to progress the development of oral immunotherapies to treat food allergies. The partnership will assess the world’s best documented probiotic strain LGG® in a Phase III clinical trial to develop a treatment for peanut allergy.
April 18, 2018
·
4 min read
1 of 2,041
Next